Skip to main content
. 2020 Jul 11;20:96. doi: 10.1186/s12894-020-00668-5

Table 3.

Schedule of enrollment, interventions, and assessments

Study period
Pre-screening Treatment
Timepoint: Visit 1 Visit 2 Visit 3 Visit 4 Visit 5
Day −28 to −14 Day −14 to − 1 Day 0 Day 5 Day 6 Day 7 Day 26 Day 27 Day 28
Enrollment:
 Eligibility screen X
 Informed concent X
 Registration X
Intervention:
 Desmopressin
Assessment:
 Patient characteristcs X
 Blood test X X X X
 PSQI X X
 EEG X X X X X
 VAS X X X
 FVC X X X X X
 Checking for AEs X X

AEs adverse events